European and Developing Countries Clinical Trials Partnership (EDCTP)
A second phase of EDCTP was launched in 2014 as part of Horizon 2020, the current EU Framework Programme for Research and Innovation 2014-2020. Member states and the European Commission together with partner states in sub-Saharan Africa have developed a 10-year programme focused on late phase (phase 3) intervention studies on products against HIV, TB and malaria also extending into neglected tropical diseases and post-efficacy studies (phase 4) including health systems optimisation.
All awards made by the MRC within the scope of EDCTP2 during 2014-2020 will form part of the UK contribution to the EDCTP2 programme supported by the European Union.
See the EDCTP website for more information.